read time: 8 minutes
Pathology & Laboratory Medicine
In the fight against cancer, survival rates improve dramatically when cancer is diagnosed early and the disease can be limited to its point of origin.1 Liquid biopsy testing shows potential to improve and accelerate cancer diagnosis by identifying certain biomarkers circulating in the blood that indicate the presence of tumors. The broad availability of well-validated and affordable laboratory blood tests that can identify several cancers at once would be a major advancement for cancer screening and patient outcomes. In this article for CLP, Yuri Fesko MD, vice president for Medical Affairs at Quest Diagnostics, outlines 4 steps to clear the way for these potential technologies.